Evidence map›Paper›PMID 41295349›Full record

ReviewJournal of cardiovascular development and disease2025

Unusual, Uncommon, Intriguing, and Significant Causes of Kounis Syndrome: Important Medications and Chemicals Used to Treat Kounis Syndrome and Myocardial Infarction Can Cause Kounis Syndrome.

Nicholas G Kounis, Cesare de Gregorio, Ming-Yow Hung, Grigorios Giamouzis, Marina A Michalaki, Uğur Özkan, Alexandr Ceasovschih, Virginia Mplani, Periklis Dousdampanis, Sophia N Kouni and 5 more

Abstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicholas G KounisDepartment of Cardiology, University of Patras Medical School, Rio, 26500 Patras, Greece.ORCID 0000-0002-9751-6710
Cesare de GregorioDepartment of Clinical and Experimental Medicine, University of Messina Medical School, 98122 Messina, Italy.ORCID 0000-0003-3022-266X
Ming-Yow HungDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, 18 No. 291, Zhongzheng Rd., Zhonghe District, New Taipei City 23561, Taiwan.ORCID 0000-0002-6912-7523
Grigorios GiamouzisDepartment of Cardiology, University Hospital of Larissa, 41334 Larissa, Greece.ORCID 0000-0002-7406-5427
Marina A MichalakiDepartment of Internal Medicine, Division of Endocrinology, University of Patras School of Health Sciences, Rio, 26500 Patras, Greece.ORCID 0000-0003-2073-8523
Uğur ÖzkanDepartment of Cardiology, School of Medicine, Trakya University, 22030 Edirne, Turkey.ORCID 0000-0002-7552-7654
Alexandr CeasovschihFaculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-0043-9051
Virginia MplaniIntensive Care Unit, Patras University Hospital, Rio, 26500 Patras, Greece.ORCID 0000-0003-1610-0156
Periklis DousdampanisDepartment of Nephrology, Saint Andrews State General Hospital, 26221 Patras, Greece.
Sophia N KouniSpeech Therapy Practice, Queen Olgas Square, 26221 Patras, Greece.ORCID 0009-0008-2544-1044
Alexandros StefanidisFirst Cardiology Department, General Hospital of Nikea, Agios Panteleimon Piraeus, 3 D. Mantouvalou Street, 18454 Piraeus, Greece.ORCID 0000-0001-5814-1859
Kassiani-Maria NastouliDepartment of Cardiology, University of Patras Medical School, Rio, 26500 Patras, Greece.ORCID 0009-0005-3320-408X
Maria BozikaDepartment of Cardiology, University of Patras Medical School, Rio, 26500 Patras, Greece.ORCID 0009-0004-8215-427X
Nicholas PatsourasDepartment of Cardiology, University of Patras Medical School, Rio, 26500 Patras, Greece.
Ioanna KoniariDepartment of Cardiology, University of Patras Medical School, Rio, 26500 Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cell degranulation and other interacting and linked cells, including T-lymphocytes, macrophages, eosinophils, and platelets, as well as a range of inflammatory mediators produced during an anaphylactic or allergic reaction, constitute the main causes of Kounis syndrome. Acute ischemia episodes, coronary spasm, atheromatous plaque erosion/rupture, and platelet activation can all be caused by histamine, tryptase, arachidonic acid derivatives, and chymase in the Kounis syndrome cascade. Kounis syndrome can be triggered by a variety of factors, including medications, hymenopteran stings, metals, foods, environmental exposures, illnesses, and immunizations. In addition, some unusual, rare, intriguing, and significant causes of Kounis syndrome have been discovered recently, namely the "kiss of death", where human kissing and pet kissing can induce fatal Kounis syndrome. Moreover, the clinical conundrum is that several of the main drugs and substances used to treat myocardial infarction and Kounis syndrome, such as adrenaline (epinephrine), aspirin, atropine, clopidogrel, corticosteroids, heparins, protamine sulfate, and hirudotherapy can also initiate it. Therefore, physicians should be aware of this clinical discrepancy to prevent catastrophic consequences.

Indexed as

adrenalineaspirinatropineclopidogrelcorticosteroidsheparinhirudotherapykissesKounis syndromeleechprotamine sulfate

Identifiers

PMID41295349
PMCPMC12653171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.